GO:0016888 DNA endonuclease activity, producing 5'-phosphomonoesters: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016888 describes the molecular function of hydrolyzing ester linkages within DNA to create internal breaks that yield 5'-phosphomonoesters.
• This activity is essential for DNA repair, recombination, and apoptosis, and is carried out by diverse endonucleases such as APE1, T7 endonuclease I, and mitochondrial structure-selective enzymes [1,2,5].
• Defects in DNA endonucleases are linked to xeroderma pigmentosum, cancer, and impaired clearance of neutrophil extracellular traps (NETs) in inflammatory diseases [4,7,8].
• CRISPR-based knockout, knock-in, and point-mutation models enable precise dissection of endonuclease function in human cells and animal models [3,4].
• Therapeutic modulation of DNase activity, including engineered dual-active DNase1 variants, shows promise for treating antimyeloperoxidase glomerulonephritis and ricin-induced acute lung injury [3,4,7].
• Studying GO:0016888 requires integrating biochemical assays, structural biology, and functional genomics to link molecular mechanisms to disease phenotypes [1,5,8].
Description
DNA endonuclease activity, producing 5'-phosphomonoesters (GO:0016888) is a fundamental molecular function that introduces internal breaks in DNA while generating 5'-phosphomonoester termini. This activity is central to DNA repair, recombination, and apoptotic DNA fragmentation, and it is executed by a wide range of enzymes that recognize specific DNA structures or lesions [1,2,5]. Understanding this function is critical for researchers studying genome stability, cell death, and inflammatory diseases [6,8]. Recent studies have highlighted the role of structure-selective endonucleases in mitochondrial DNA inheritance and the therapeutic potential of DNase enzymes in conditions such as antimyeloperoxidase glomerulonephritis and acute lung injury [2,3,7]. Moreover, deficiencies in apurinic/apyrimidinic endonucleases have been linked to xeroderma pigmentosum, underscoring the clinical relevance of this activity. As CRISPR-based models become more sophisticated, precise manipulation of genes encoding these endonucleases will accelerate discoveries in DNA repair and disease mechanisms [3,4].
DNA endonuclease activity, producing 5'-phosphomonoesters At A Glance
| GO ID | GO:0016888 |
|---|---|
| GO term | DNA endonuclease activity, producing 5'-phosphomonoesters |
| Ontology | molecular_function |
| Synonym | endodeoxyribonuclease activity, producing 5' phosphomonoesters; endodeoxyribonuclease activity, producing 5'-phosphomonoesters |
| Definition | Catalysis of the hydrolysis of ester linkages within deoxyribonucleic acids by creating internal breaks to yield 5'-phosphomonoesters. |
| Major function | DNA cleavage during repair, recombination, and apoptosis |
| Representative enzymes | APE1, T7 endonuclease I, DNase1, mitochondrial structure-selective endonucleases |
| Cofactors | Mg2+ or other divalent metal ions (for many enzymes) |
| Subcellular locations | Nucleus, mitochondria, extracellular space (for secreted DNases) |
What Is GO:0016888?
GO:0016888 is defined as the catalysis of the hydrolysis of ester linkages within deoxyribonucleic acids by creating internal breaks to yield 5'-phosphomonoesters. In simpler terms, it is the function of enzymes that cut DNA internally, leaving a phosphate group on the 5' end of the break. This activity is distinct from exonucleases, which degrade DNA from the ends, and from endonucleases that produce 3'-phosphomonoesters.
Why Is DNA endonuclease activity, producing 5'-phosphomonoesters Important in Cell Biology?
DNA endonuclease activity producing 5'-phosphomonoesters is essential for maintaining genome integrity and regulating cell fate. It enables the removal of damaged DNA bases, the resolution of recombination intermediates, and the execution of apoptotic DNA fragmentation [1,5,6]. Dysregulation of this activity contributes to cancer, neurodegenerative disorders, and inflammatory diseases, while its therapeutic activation can mitigate tissue damage in conditions such as glomerulonephritis and acute lung injury [3,4,7]. Thus, understanding this function is vital for developing targeted therapies and for interpreting genetic variants in DNA repair genes.
• Enables DNA repair by cleaving abasic sites and damaged bases, as demonstrated for APE1.
• Facilitates apoptotic DNA fragmentation, a hallmark of programmed cell death.
• Required for mitochondrial DNA inheritance and structure-selective cleavage.
• Deficiency in apurinic/apyrimidinic endonuclease activity is associated with xeroderma pigmentosum.
• Therapeutic DNase enzymes degrade neutrophil extracellular traps (NETs) to attenuate inflammation [4,7].
• Engineered DNase1 variants enhance treatment of antimyeloperoxidase glomerulonephritis.
• T7 endonuclease I cleaves UV-induced DNA lesions, linking this activity to UV damage repair.
• Modulating endonuclease activity can protect against ricin-induced acute lung injury and ARDS.
• CRISPR screens can identify genes encoding endonucleases that affect drug sensitivity and DNA damage responses.
• Biochemical and structural studies of these enzymes inform inhibitor and activator design [1,5].
What Happens During DNA endonuclease activity, producing 5'-phosphomonoesters?
Substrate recognition and binding
In simple terms: The enzyme finds and attaches to a specific DNA structure or damaged site.
Endonucleases recognize distinct DNA features such as abasic sites, UV-induced lesions, or branched structures. For example, T7 endonuclease I binds structure-specifically to DNA containing UV-induced lesions. Human APE1 recognizes abasic sites and non-canonical RNA structures. Mitochondrial structure-selective endonucleases target recombination intermediates to drive uniparental inheritance.
Catalytic cleavage and 5'-phosphomonoester formation
In simple terms: The enzyme cuts the DNA backbone, leaving a phosphate on the 5' end.
Hydrolysis of the phosphodiester bond occurs via a metal-ion-dependent mechanism, generating a 5'-phosphomonoester and a 3'-hydroxyl group. This cleavage is central to the definition of GO:0016888. APE1 incises DNA at abasic sites, producing 5'-deoxyribose phosphate termini. DNase1 and its variants cleave extracellular DNA, including NETs, to yield 5'-phosphomonoesters [4,7].
Downstream processing and repair
In simple terms: After cutting, other enzymes finish the repair or degradation process.
The 5'-phosphomonoester ends serve as substrates for DNA polymerases and ligases during repair, or they mark DNA for further degradation. In apoptosis, endonuclease-generated breaks lead to DNA fragmentation. In NET degradation, DNase1-mediated cleavage dismantles chromatin structures, reducing inflammation [4,7].
Regulation and cofactor requirements
In simple terms: The activity is controlled by metal ions and interacting proteins.
Many endonucleases require divalent metal ions such as Mg2+ or Ca2+ for catalysis. APE1 activity is influenced by its interaction with other base excision repair proteins. The activity of DNase1 variants can be engineered for enhanced stability and dual functionality. Mitochondrial endonucleases are regulated by factors that ensure uniparental inheritance.
Key Genes Involved in GO:0016888 DNA endonuclease activity, producing 5'-phosphomonoesters
The following genes encode enzymes that exhibit DNA endonuclease activity producing 5'-phosphomonoesters, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| APEX1 | Major apurinic/apyrimidinic endonuclease in base excision repair | Studied for its role in DNA repair and cancer therapy resistance |
| DNASE1 | Secreted endonuclease that cleaves extracellular DNA | Therapeutic target in glomerulonephritis and NET-related diseases [3,4] |
| DNASE1L3 | Endonuclease involved in chromatin degradation | Implicated in autoimmunity and inflammation |
| T7 endonuclease I (viral) | Structure-specific endonuclease from bacteriophage T7 | Model enzyme for studying UV lesion cleavage |
| EXOG | Mitochondrial endonuclease involved in DNA repair | Linked to mitochondrial DNA maintenance |
| ENDOG | Endonuclease G, involved in apoptotic DNA fragmentation | Studied in cell death pathways |
| FEN1 | Flap endonuclease involved in DNA replication and repair | Relevant to genome stability and cancer |
| XPF | Structure-specific endonuclease in nucleotide excision repair | Defective in xeroderma pigmentosum |
| ERCC1 | Partners with XPF in DNA repair | Biomarker for platinum-based chemotherapy |
| MRE11 | Endonuclease involved in double-strand break repair | Target for cancer radiosensitization |
| RAD50 | Part of MRN complex with endonuclease activity | Studied in DNA damage response |
| NTHL1 | DNA glycosylase/lyase with endonuclease activity | Associated with colorectal cancer |
| OGG1 | 8-oxoguanine DNA glycosylase with lyase activity | Linked to oxidative DNA damage repair |
| APE2 | Apurinic/apyrimidinic endonuclease | Less characterized, potential backup for APE1 |
| DCLRE1C | Artemis, involved in V(D)J recombination | Defective in severe combined immunodeficiency |
| SETMAR | Metnase, has endonuclease activity | Studied in non-homologous end joining |
| MUS81 | Structure-specific endonuclease | Involved in replication fork repair |
How Is DNA endonuclease activity, producing 5'-phosphomonoesters Regulated?
The activity of DNA endonucleases producing 5'-phosphomonoesters is regulated at multiple levels. Post-translational modifications, such as phosphorylation and acetylation, can modulate enzyme activity and localization. Protein-protein interactions, for example within the MRN complex, influence substrate specificity and catalytic efficiency. Metal ion availability and redox conditions also affect activity, as seen for APE1. In the extracellular space, DNase1 activity is regulated by inhibitors such as actin, and engineered variants can bypass such inhibition. Mitochondrial endonucleases are controlled by factors that ensure uniparental inheritance and are subject to developmental regulation.
DNA endonuclease activity, producing 5'-phosphomonoesters and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APEX1 | Xeroderma pigmentosum, cancer | Knockout in human fibroblasts, point mutation of catalytic residues |
| DNASE1 | Antimyeloperoxidase glomerulonephritis, acute lung injury | Overexpression of dual-active variants in mouse models [3,4] |
| DNASE1L3 | Autoimmunity, NET-related inflammation | Knockout mice, knock-in of human variants |
| ENDOG | Apoptosis, neurodegeneration | Knockout in neuronal cell lines, overexpression studies |
| EXOG | Mitochondrial DNA depletion syndromes | Knockout in HeLa cells, mitochondrial import assays |
Xeroderma pigmentosum and DNA repair deficiencies
Deficient DNA binding of an apurinic/apyrimidinic endonuclease activity has been observed in cells from xeroderma pigmentosum patients, linking impaired endonuclease function to UV sensitivity and cancer predisposition. This highlights the importance of GO:0016888 in nucleotide excision repair and base excision repair pathways.
Inflammatory diseases and NET degradation
DNase1 and its variants degrade neutrophil extracellular traps (NETs), and this activity is protective in antimyeloperoxidase glomerulonephritis and ricin-induced acute lung injury [3,4,7]. Enhancing DNase activity through gene therapy or engineered enzymes represents a therapeutic strategy for inflammatory conditions [3,4].
Apoptosis and cell death
Endonuclease-mediated DNA fragmentation is a hallmark of apoptosis, and mechanisms of cell death often involve activation of endonucleases that produce 5'-phosphomonoesters. Understanding these pathways is relevant to cancer therapy and neurodegeneration.
Mitochondrial DNA inheritance and disease
A structure-selective endonuclease drives uniparental mitochondrial DNA inheritance, and defects in this process can lead to mitochondrial diseases. This underscores the role of GO:0016888 in mitochondrial genome maintenance.
From DNA endonuclease activity, producing 5'-phosphomonoesters-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does APEX1 endonuclease activity protect against UV damage? | APEX1 knockout and point-mutation (catalytic dead) cell lines [5,8] |
| Can engineered DNase1 variants treat glomerulonephritis? | Knock-in mice expressing dual-active DNase1, or overexpression via gene therapy [3,4] |
| What is the role of mitochondrial endonuclease in mtDNA inheritance? | Knockout of EXOG in cell lines, followed by mtDNA sequencing |
| How does T7 endonuclease I recognize UV lesions? | In vitro cleavage assays with purified enzyme and defined DNA substrates |
| Is ENDOG required for apoptotic DNA fragmentation? | ENDOG knockout cells treated with apoptotic stimuli, followed by DNA laddering |
| Can CRISPR screens identify novel endonucleases? | Genome-wide knockout library screening in cells exposed to DNA-damaging agents |
How to Study the DNA endonuclease activity, producing 5'-phosphomonoesters Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro cleavage assay | DNA cleavage activity and product analysis | Characterizing purified endonucleases |
| Comet assay | DNA breaks in cells | Assessing endonuclease activity in response to damage |
| CRISPR knockout screening | Gene essentiality and drug sensitivity | Identifying novel endonucleases in DNA repair |
| Site-directed mutagenesis | Effect of point mutations on catalysis | Mapping catalytic residues |
| Structural biology (X-ray/cryo-EM) | 3D structure of enzyme-DNA complexes | Understanding mechanism [2,5] |
| NET degradation assay | Extracellular DNA cleavage | Evaluating DNase therapeutics [4,7] |
| Apoptosis assays (TUNEL, DNA laddering) | Apoptotic DNA fragmentation | Studying ENDOG and other endonucleases |
| Mitochondrial DNA sequencing | mtDNA inheritance patterns | Investigating mitochondrial endonucleases |
Biochemical cleavage assays
In vitro assays using purified endonucleases and defined DNA substrates (e.g., plasmid DNA, oligonucleotides) can measure cleavage efficiency and product formation. For example, T7 endonuclease I activity on UV-damaged DNA was assessed by gel electrophoresis. APE1 activity on abasic site-containing DNA is commonly measured using radiolabeled substrates.
CRISPR-based functional genomics
Genome-wide CRISPR knockout screens can identify genes whose loss alters sensitivity to DNA-damaging agents or affects NET degradation. Such screens have been used to discover modulators of DNase1 therapy. Point-mutation knock-in models allow precise dissection of catalytic residues.
Structural biology and modeling
X-ray crystallography and cryo-EM provide atomic-level insights into substrate binding and catalysis. Structural studies of APE1 and mitochondrial endonucleases have revealed key residues for 5'-phosphomonoester production [2,5].
Disease model phenotyping
Animal models, such as mice with DNase1 or DNase1L3 deletions, are used to study inflammatory diseases and autoimmunity. Overexpression of engineered DNase variants via gene therapy can be evaluated in glomerulonephritis models [3,4].
How CRISPR Can Be Used to Study GO:0016888 DNA endonuclease activity, producing 5'-phosphomonoesters
Knockout
CRISPR knockout of genes encoding DNA endonucleases (e.g., APEX1, DNASE1) allows researchers to assess loss-of-function phenotypes, such as increased sensitivity to DNA-damaging agents or impaired NET degradation [3,5]. Knockout cell lines are valuable for validating drug targets and understanding disease mechanisms.
Point Mutation
Introducing point mutations in catalytic residues (e.g., in APEX1 or DNASE1) via CRISPR base editing or homology-directed repair can separate endonuclease activity from other functions. Such models help define the precise contribution of 5'-phosphomonoester production to biological processes [4,5].
Knock-in
Knock-in of tagged or variant endonucleases (e.g., fluorescently tagged APE1 or dual-active DNase1) enables real-time imaging and tracking of enzyme localization and activity. Knock-in mouse models expressing human variants can be used to test therapeutic efficacy [3,4].
Overexpression
Overexpression of wild-type or engineered endonucleases (e.g., DNase1 variants) can enhance DNA cleavage in disease models, such as glomerulonephritis or acute lung injury. This approach is used to evaluate therapeutic potential and dose-response effects [3,4,7].
How EDITGENE Supports DNA endonuclease activity, producing 5'-phosphomonoesters Research
Researchers studying DNA endonuclease activity, producing 5'-phosphomonoesters-related genes often need to determine whether a candidate gene is causally involved in DNA repair, inflammation, or cell death. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling functional validation of endonuclease genes and their variants.
Contact EDITGENE today to design your custom CRISPR model for DNA endonuclease activity, producing 5'-phosphomonoesters research.
Frequently Asked Questions About DNA endonuclease activity, producing 5'-phosphomonoesters
What is DNA endonuclease activity, producing 5'-phosphomonoesters?
It is a molecular function (GO:0016888) where an enzyme cuts DNA internally, leaving a phosphate group on the 5' end of the break.
What genes are involved in DNA endonuclease activity, producing 5'-phosphomonoesters?
Key genes include APEX1, DNASE1, DNASE1L3, ENDOG, EXOG, and T7 endonuclease I (viral), among others [1,2,3,5].
How is DNA endonuclease activity measured?
Common methods include in vitro cleavage assays, comet assays, and CRISPR-based functional screens [1,3,5].
What diseases are linked to defects in DNA endonucleases?
Xeroderma pigmentosum, inflammatory diseases like glomerulonephritis, and acute lung injury have been associated with altered endonuclease activity [3,4,7,8].
Can CRISPR be used to study DNA endonuclease activity?
Yes, CRISPR knockout, knock-in, and point mutation models enable precise functional studies of endonuclease genes [3,4,5].
What is the role of APE1 in DNA endonuclease activity?
APE1 is a major apurinic/apyrimidinic endonuclease that incises DNA at abasic sites, producing 5'-phosphomonoesters.
How does DNase1 help in inflammatory diseases?
DNase1 degrades neutrophil extracellular traps (NETs), reducing inflammation in conditions like glomerulonephritis and acute lung injury [3,4,7].
What is the difference between endonuclease and exonuclease?
Endonucleases cut DNA internally, while exonucleases degrade DNA from the ends; GO:0016888 specifically refers to endonucleases producing 5'-phosphomonoesters.
Which model organisms are used to study DNA endonucleases?
Mouse models, human cell lines, and viral enzymes like T7 endonuclease I are commonly used [1,3,4].
How can EDITGENE help with my research on DNA endonucleases?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to study endonuclease function and disease relevance [3,5].
Conclusion
DNA endonuclease activity, producing 5'-phosphomonoesters (GO:0016888) is a critical molecular function with broad implications for genome stability, cell death, and inflammation. Understanding its mechanisms and regulation offers insights into diseases ranging from xeroderma pigmentosum to acute lung injury. Leveraging CRISPR-based models and EDITGENE services can accelerate the translation of these findings into therapeutic strategies.
References
- 1. Matsubara K et al.. 2024. Structure-specific DNA endonuclease T7 endonuclease I cleaves DNA containing UV-induced DNA lesions.. J Biochem 176(1):35-42 PMID: 38426948
- 2. Shimomura M et al.. 2026. A structure-selective endonuclease drives uniparental mitochondrial DNA inheritance.. bioRxiv PMID: 41889885
- 3. Cao Le A et al.. 2025. Gene therapy enhances deoxyribonuclease I treatment in antimyeloperoxidase glomerulonephritis.. JCI Insight 10(15) PMID: 40632882
- 4. Englert H et al.. 2023. Targeting NETs using dual-active DNase1 variants.. Front Immunol 14:1181761 PMID: 37287977
- 5. Davletgildeeva AT et al.. 2020. Activity of Human Apurinic/Apyrimidinic Endonuclease APE1 Toward Damaged DNA and Native RNA With Non-canonical Structures.. Front Cell Dev Biol 8:590848 PMID: 33195255
- 6. Fawthrop DJ et al.. 1991. Mechanisms of cell death.. Arch Toxicol 65(6):437-44 PMID: 1929863
- 7. Sapoznikov A et al.. 2025. NET degradation attenuates ricin-induced acute lung injury and protects mice from ARDS.. Mol Med 31(1):304 PMID: 41023796
- 8. Bickley LK et al.. 1988. Deficient DNA binding of an apurinic/apyrimidinic DNA endonuclease activity from xeroderma pigmentosum cells.. Cell Biol Int Rep 12(3):231-7 PMID: 2454750
